Medical Communications

Showing 15 posts of 6402 posts found.

christian_dillon

Christian Dillon announced as Vice President of Biology at PhoreMost

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.In this new role, Dr Dillon will …
serap_becker

Ashfield Engage appoints new Head of Patient Solutions

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield Engage, part of UDG Healthcare plc, has appointed Serap Becker as Head of Patient Solutions for the DACH region.Joining …
pers

Personalised medicine in oncology: Where are we now?

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …

Novartis appoints Alessandra Dorigo as General Manager

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …

Tapeworm drug to be trialled nationally as COVID treatment

June 25, 2021 Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm

Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …

Eli Lilly to seek FDA approval for experimental Alzheimer’s drug

June 25, 2021 Medical Communications Alzheimer's, Eli Lilly, FDA

Eli Lilly plans to seek accelerated FDA approval for its experimental Alzheimer’s drug donanemab, announcing plans on Thursday to file …
laboratory-testing-az

Exscientia to collaborate with EQRx on drug development

June 25, 2021 Medical Communications AI, Exscientia, clinical drug development

Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …

New test proven to detect over 50 types of cancer

June 25, 2021 Medical Communications Cancer. test, US, oncology

Final results from a study into a new blood test that can detect more than 50 types of cancer have …
sanofi_hq__boetie_hall_small_

Sanofi’s NSCLC drug gains EC approval

June 25, 2021 Medical Communications EC, EU, NSCLC, Sanofi

The European Commission (EC) has approved Sanofi and Regeneron’s PD-1 inhibitor, Libtayo (cemiplimab), for the first-line treatment of adults with …

Breakthrough announced in circulating tumour cell research

June 18, 2021 Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology

Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …

UK AI firm wins share of £140 million funding for lung cancer detection tech

June 18, 2021 Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology

Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …
astrazeneca_plaque

Australia pauses AstraZeneca vaccine for people under 60

June 18, 2021 Medical Communications AstraZeneca, Australia, COVID-19, Vaccine

Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …

New class of cancer-killing drugs identified

June 18, 2021 Medical Communications Cancer, oncology

Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …

NICE recommends two new treatments for inflammatory arthritis

June 18, 2021 Medical Communications Eli Lilly, NICE, Novartis

NICE has recommended two new treatments for axial spondyloarthritis, an underdiagnosed and debilitating type of inflammatory arthritis. Ixekizumab (also known …
The Gateway to Local Adoption Series

Latest content